ROVI expresses its deepest sorrow at the death of Ms Fátima Báñez and its solidarity with the other victims of the railway accident in Urda (Toledo)


Madrid, 29 October 2026  

Laboratorios Farmacéuticos ROVI expresses its deepest sorrow at the passing of Ms Fátima Báñez García, an independent member of the company’s Board of Directors, and all those who lost their lives in yesterday’s tragic railway accident that occurred in Urda (Toledo). The company extends its condolences to the families of all those affected.

Fátima Báñez had been a member of ROVI’s Board of Directors since December 2019 and served on the Audit Committee and the Nomination and Remuneration Committee. During this time, she made a very significant contribution to the company’s development through her experience, knowledge and strategic vision, as well as her ability to build consensus. ROVI particularly wishes to underline her commitment and dedication, as well as the warmth and empathy that always characterised her relationship with the company.

The loss of Fátima Báñez comes as very sad news for everyone who had the opportunity to work with her and share part of her professional journey. Beyond her widely recognised professional abilities, those who knew her highlight her personal warmth, generosity and constant willingness to listen, engage in dialogue and contribute to the common good.

ROVI’s Chairman and Chief Executive Officer, Juan López-Belmonte, has conveyed his most sincere condolences to Fátima Báñez’s family, friends and loved ones on behalf of the Board of Directors, the management team and everyone at the company.

"Today is a day of immense sadness for everyone at ROVI. Fátima leaves an indelible mark on our company and on those of us who had the good fortune and privilege of working with her. We will always remember her commitment and valuable contributions to ROVI but, above all, her outstanding personal qualities, her warmth and her approach to serving others. We wish to extend our heartfelt support to her family and to everyone who shared her life and professional journey,” said Juan López-Belmonte.

ROVI would also like to extend its solidarity and heartfelt sympathies to the families and loved ones of the rest of the victims of this tragedy, offering them its support during these difficult times.

Rest in peace.

No votes yet
 
Related
​Operating revenue in the first half of 2025 was 314.6 million euros, a 4% decrease on the first half of 2024, mainly due to the...
3 min
24/07/2025
  Madrid, 10 July 2025. Laboratorios Farmacéuticos ROVI, S.A. (“ROVI”) announces that, on 9 July 2025, the Technological...
4 min
10/07/2025
ROVI continues with its shareholder remuneration policy after completing the third consecutive share buyback programme last year and...
5 min
18/06/2025